Clinical Trial Update: Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase I pharmacokinetic and safety study in healthy volunteers evaluating co-administration of L03RD1 and L03RD2 or CT-L03; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CT-L03
• L03RD1
• L03RD2

Snippet

Sponsor: Celltrion | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Status: COMPLETED